A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

C Avendaño-Solá, A Ramos-Martínez… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Passive immunotherapy with convalescent plasma (CP) is a potential
treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. METHODS We …

Convalescent plasma for COVID-19: a multicenter, randomized clinical trial

C Avendano-Sola, A Ramos-Martinez, E Munez-Rubio… - MedRxiv, 2020 - medrxiv.org
Background Passive immunotherapy with convalescent plasma (CP) is a potential treatment
for COVID-19 for which evidence from controlled clinical trials is lacking. Methods We …

Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis

P Domingo, I Mur, GM Mateo, M del Mar Gutierrez… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …

Patient involvement in clinical research: why, when, and how

JA Sacristán, A Aguarón… - Patient preference …, 2016 - Taylor & Francis
The development of a patient-centered approach to medicine is gradually allowing more
patients to be involved in their own medical decisions. However, this change is not happening …

Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY …

G Ducrocq, JR Gonzalez-Juanatey, E Puymirat… - Jama, 2021 - jamanetwork.com
Importance The optimal transfusion strategy in patients with acute myocardial infarction and
anemia is unclear. Objective To determine whether a restrictive transfusion strategy would …

A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality

A Fernández-Cruz, B Ruiz-Antorán… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Evidence to support the use of steroids in coronavirus disease 2019 (COVID-19) pneumonia
is lacking. We aim to determine the impact of steroid use for COVID-19 pneumonia on …

Association of convalescent plasma treatment with clinical status in patients hospitalized with COVID-19: a meta-analysis

AB Troxel, E Petkova, K Goldfeld, M Liu… - JAMA Network …, 2022 - jamanetwork.com
Importance COVID-19 convalescent plasma (CCP) is a potentially beneficial treatment for
COVID-19 that requires rigorous testing. Objective To compile individual patient data from …

[HTML][HTML] Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells …

E Gómez-Barrena, P Rosset, F Gebhard, P Hernigou… - Biomaterials, 2019 - Elsevier
Background ORTHO-1 is a European, multicentric, first in human clinical trial to prove safety
and feasibility after surgical implantation of commercially available biphasic calcium …

Development and validation of a treatment benefit index to identify hospitalized patients with COVID-19 who may benefit from convalescent plasma

H Park, T Tarpey, M Liu, K Goldfeld, Y Wu… - JAMA network …, 2022 - jamanetwork.com
Importance Identifying which patients with COVID-19 are likely to benefit from COVID-19
convalescent plasma (CCP) treatment may have a large public health impact. Objective To …

Impact of glucocorticoid treatment in SARS-CoV-2 infection mortality: a retrospective controlled cohort study

A Fernández Cruz, B Ruiz-Antoran, AM Gómez… - medRxiv, 2020 - medrxiv.org
Objective We aim to determine the impact of steroid use in COVID-19 pneumonia in-hospital
mortality. Design We performed a single-centre retrospective cohort study. Setting A …